Reelabs Private Limited, a active private limited company, was established on 23 February 2009 in Mumbai, Maharashtra, India. Engaging in biotechnology within the hospital and medical care sector, it holds CIN: U85100MH2009PTC190531. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.23 Cr.
Formerly known as Ree Labs Private Limited, Ree Laboratories Private Limited. It upholds a compliant status. Employing 45 professional, Its leadership includes Rohit Ramchandra Kulkarni (Director), Abhijit Shyamsunder Bopardikar (Director), Sunil Haripant Pophale (Managing Director). It holds ₹20.50 Cr open charges and ₹35.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1St Floor, K.K. Chambers, Sir.P.T.Road, Fort, Mumbai, Maharashtra, 400001.
U85100MH2009PTC190531
190531
23 February 2009
₹4.00 Cr
₹2.23 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Reelabs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Ramchandra Kulkarni | Director | 23 Feb 2009 | Current |
| Abhijit Shyamsunder Bopardikar | Director | 23 Feb 2009 | Current |
| Sunil Haripant Pophale | Managing Director | 23 Feb 2009 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reelabs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.41% increase. The company also saw a substantial improvement in profitability, with a 64.61% increase in profit. The company's net worth Soared by an impressive increase of 17.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Reelabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹205,000,000.00
₹350,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹20.50 Cr | Open |
| 17 Nov 2023 | Others | ₹15.00 Cr | Satisfied |
| 15 Mar 2022 | Others | ₹5.00 Cr | Satisfied |
| 15 Mar 2022 | Others | ₹5.00 Cr | Satisfied |
| 29 Dec 2014 | Nkgsb Cooperative Bank Limited | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Reelabs has a workforce of 45 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Reelabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reelabs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 17 Nov 2023 via Charge ID 100823208 with Others was fully satisfied on 14 Nov 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 20.50 Cr with Charge ID 100988188 was registered on 30 Sep 2024. was recorded as a recent event.
Reelabs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Reelabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100823208 was registered on 17 Nov 2023. was documented.
Progress on A charge registered on 15 Mar 2022 via Charge ID 100565701 with Others was fully satisfied on 25 Oct 2023. was documented.
The CIN of Reelabs Private Limited is U85100MH2009PTC190531.
Reelabs Private Limited is headquartered at 1St Floor, K.K. Chambers, Sir.P.T.Road, Fort, Mumbai, Maharashtra, 400001.
Reelabs Private Limited was incorporated on 23 February 2009.
The current directors of Reelabs Private Limited are
The primary industry of Reelabs Private Limited is Hospital And Medical Care.
Reelabs Private Limited is unlisted.
The authorized capital of Reelabs Private Limited is ₹4.00 Cr, and the paid-up capital is ₹2.23 Cr.
The compliance status of Reelabs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX